Manjinder Kaur, Ph.D. (she/her/hers)

Pharmacologist
US Food and Drug Administration

Poster(s):

• (M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
  Monday, October 21, 2024

  10:30 AM – 11:30 AM MT

• (M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
  Monday, October 21, 2024

  2:30 PM – 3:30 PM MT